Norrsken Foundation is a founding partner in Cellcolabs, a venture originally set up by investment company Takura. Our vision is to dramatically scale up the production of mesenchymal stem cells, making them available at much lower cost and for a much wider range of treatments than currently.
ABC Labs was created as a direct response to challenges posed by the coronavirus to the Swedish healthcare system. The company, which provides rapidly scalable, state-of-the-art PCR and ELISA testing, was initially built and deployed over seven weeks. It now consistently represents up to 25% of all national testing for Covid-19 with over 2.7 million tests completed.
A week filled with intellectual conversations and meaningful meetings that gathers CEOs, top talents, policymakers, entrepreneurs, and startups under the same roof with the purpose of inspiring everyone to take action and be a driving force for change.
The world needs better role-models. That's why we created the Impact/100. It's an annual ranking of the world's most promising impact startups. It exists to spotlight and make role-models out of the visionary entrepreneurs who are changing the world for the better. Because if they win, we all win.
With global rates of mental health issues like depression, anxiety and addiction remaining high, current treatments are struggling to keep up. We’re proud to launch Norrsken MindPsychedelic Science Initiative. A Swedish non-profit initiative focused on supporting research on psychedelic-assisted treatments.
Sometimes we embark on initiatives of our own. This can mean launching completely new ventures, or partnering with brilliant entrepreneurs to provide funding, amplification or expertise.
These are typically high-risk projects with the potential to drive significant positive impact on a global scale. We believe this is unexplored territory in a world where nonprofits avoid financial risk, and venture capitalists focus only on financial returns.
